Immune responses to vaccines require direct recognition of pathogen-associated molecular patterns (PAMPs) through patternrecognition receptors (PRRs) on dendritic cells (DCs). Unlike vaccination, infection by a live pathogen often impairs DC function and inflicts additional damage on the host. Here we found that after infection with live influenza A virus, signaling through the interleukin 1 receptor (IL-1R) was required for productive priming of CD8 + T cells, but signaling through the PRRs TLR7 and RIG-I was not. DCs activated by IL-1 in trans were both required and sufficient for the generation of virus-specific CD8 + T cell immunity. Our data demonstrate a critical role for a bystander cytokine in the priming of CD8 + T cells during infection with a live virus. 
A r t i c l e s
The initiation of protective immune responses to infectious microorganisms is thought to rely on the recognition of microbes by innate sensors 1 . After infection, influenza A virus (IAV) is detected by the following three classes of innate sensors: members of the Toll-like receptor (TLR) family; RIG-I like receptors (RLRs); and Nod-like receptors (NLRs) 2 . Viral genomic single-stranded RNA is recognized by TLR7 (ref. 3, 4) and TLR8 (ref. 5) in the endosome and by RIG-I in the cytosol 6, 7 . Signaling through either RIG-I or TLR7 leads to the production of type I interferons, which limits viral replication and increases innate resistance to infection 8 . In contrast to TLRs and RLRs, which recognize viral pathogen-associated molecular patterns (PAMPs), NLRP3 senses cellular damage or distress as a consequence of infection 9 . The infected host cell recognizes IAV through NLRP3 on the basis of activity of the M2 ion channel 10 . Once activated, NLRP3 engages the inflammasome complex that includes the adaptor ASC and caspase-1, which results in the activation of caspase-1 and the cleavage of its substrates, including the proinflammatory cytokines interleukin 1β (IL-1β) and .
The relevance of host recognition of viral PAMPs versus virusinflicted damage in linking innate recognition of IAV to adaptive immunity has not been systematically explored. Neither the absence of TLR3 (ref. 12) nor the absence of the RIG-I signaling adaptor MAVS 8 diminishes adaptive immunity to IAV. In addition, Tlr7 −/− mice are able to mount an intact CD8 + T cell response despite having variable defects in CD4 + T cell responses and immunoglobulin production in response to IAV 8, 13 . In contrast, the importance of NLRP-dependent activation of inflammasomes in innate 14, 15 and adaptive 16 immune defense against IAV has been demonstrated. The requirement that the inflammasomes generate protective adaptive immunity to IAV has been attributed to the production of IL-1α and IL-1β, as mice deficient in IL-1 receptor type I (IL-1R) [16] [17] [18] suffer from a lack of immune responses similar to that of ASC-or caspase-1-deficient mice 16 . IL-1R-deficient mice have defective CD4 + T cell and antibody responses to infection with IAV 16, 17 and have impaired CD8 + T cell responses at 7 d after infection 17 and 14 d after infection 16 . Although these data collectively indicate the importance of the inflammasome-IL-1R axis in the priming of CD8 + T cells in response to IAV, it remains possible that TLR7 and RIG-I induce redundant signaling pathways that compensate for each other in mice with single deficiency in either of these PRRs.
As for the importance of direct detection of PAMPs by antigenpresenting dendritic cells (DCs) in the priming of T cell responses, published studies have shown a requirement for DC-intrinsic recognition of PAMPs via TLRs in initiating CD4 + T cell responses 19 and CD8 + T cell responses 20 after immunization with a model antigen plus a TLR ligand as adjuvant. Under those conditions, activation of bystander DCs by inflammatory cytokines alone is not sufficient to render them able to stimulate productive T cell immune responses. However, whether similar principles of T cell priming apply during infection with various other microbes remains unclear. During infection with a live pathogen, directly infected DCs are often rendered unable to prime T cells 21 . Under such circumstances, activation of bystander DCs might be required for efficient priming of T cells.
Here we examined the relative contributions of pattern recognition versus inflammasome-dependent recognition of damage in the initiation of adaptive CD8 + T cell responses after respiratory infection RESULTS IAV-specific CD8 + T cell responses require IL-1R Because mice deficient in TLR7 or MAVS alone have intact CD8 + T cell immune responses to IAV 8, 13 , we investigated whether TLR7 and RIG-I share any functional redundancy in providing the requisite signals for the activation of adaptive immune responses. We challenged mice lacking both TLR7 and MAVS (Tlr7 −/− Mavs −/− mice) intranasally with a sublethal dose of mouse-adapted IAV strain A/PR8 (H1N1; 10 plaque-forming units (PFU) per mouse; 0.4 LD 50 (dose lethal to 50% of mice tested)). This dose of A/PR8 has been shown to be optimal in demonstrating the importance of innate pathways involved in adaptive immunity-dependent clearance of IAV 16 without inducing mortality. Tlr7 −/− mice and Tlr7 −/− Mavs −/− mice mounted a much lower inflammatory response than did wildtype mice or Mavs −/− mice, including less recruitment of cells into the airway and lower production of the proinflammatory cytokine IL-6 at day 4 after infection ( Supplementary Fig. 1a,b) . The inflammatory response was the most diminished in Tlr7 −/− Mavs −/− mice and less diminished in Tlr7 −/− mice. These data indicated that the innate immune response to respiratory IAV was largely TLR7 dependent.
To examine the effect of deficiency in TLR7 and MAVS on the development of adaptive immunity to IAV, we assessed the frequency and number of virus-specific CD8 + T cells in the lungs. We detected no difference in the frequency (Fig. 1a) or number (Fig. 1b) of IAV-specific CD8 + T cells in the lungs at day 9 after infection. In contrast, Tlr7 −/− Mavs −/− mice had significantly fewer IFN-γ + CD4 + T cells in the lungs 9 d after infection with IAV (Fig. 1c) . These data indicated that whereas both the TLR7-and RIG-I-dependent recognition pathways contributed to the development of virus-specific IFN-γ-producing CD4 + T cells, CD8 + T cell responses developed in the absence of both of these PRRs.
Protective immunity to IAV is known to require ASC-and caspase-1-dependent activation of the inflammasome and IL-1R 16 . Il1r1 −/− mice mounted a much lower response to a sublethal dose of IAV than did wild-type mice, in terms of the frequency (Fig. 1a) and number (Fig. 1b) of virus-specific CD8 + T cell in the lungs and in the bronchoalveolar lavage (BAL) fluid (Fig. 1d) 9 d after infection. These results indicated a dominant role of IL-1R over TLR7 and RIG-I in the generation of CD8 + T cell responses.
We next examined the proliferative and functional abilities of IAV-specific CD8 + T cells in Il1r1 −/− mice. At 8 d after infection with a sublethal dose of IAV strain A/PR8, the number of proliferating (Ki67 + ) virus-specific CD8 + T cells was much lower in the lungs and draining mediastinal lymph nodes (mLNs) of Il1r1 −/− mice than in those of wild-type mice (Fig. 1e) . Il1r1 −/− mice also had fewer IFN-γ-producing virus-specific CD8 + T cells in the lungs and spleen than did wild-type mice (Fig. 1f) . Furthermore, there were significantly fewer polyfunctional CD8 + T cells able to secrete IFN-γ and tumor-necrosis factor and to undergo degranulation (CD107a + ) in Il1r1 −/− mLNs than in wild-type mLNs (Fig. 1g) . These results indicated that IL-1R signaling was required for the activation and population expansion of and acquisition of effector functions by CD8 + T cells after infection with IAV.
Hematopoietic lineage-intrinsic requirement for IL-1R signaling IL-1R is widely expressed by many cell types that belong to the hematopoietic and nonhematopoietic compartments 22 . To identify the cells responsible for supporting the IL-1R-dependent priming of CD8 + T cells during infection with IAV, we generated chimeras in which IL-1R expression was confined to the hematopoietic compartment (lethally irradiated Il1r1 −/− host mice given wild-type bone marrow) A r t i c l e s or the stromal compartment (lethally irradiated wild-type host mice given Il1r1 −/− bone marrow). We also generated control chimeras of lethally irradiated wild-type host mice given wild-type bone marrow, and lethally irradiated Il1r1 −/− host mice given Il1r1 −/− bone marrow. After complete reconstitution of the bone marrow, we challenged the chimeras with a sublethal dose of IAV strain A/PR8. At 9 d after infection, wild-type mice that received Il1r1 −/− bone marrow had a lower frequency and number of virus-specific CD8 + T cells in the lung and the spleen than did wild-type control mice that received wild-type bone marrow, similar to Il1r1 −/− mice that received Il1r1 −/− bone marrow ( Fig. 2a,b) . In addition, the secretion of IFN-γ from CD8 + T cells was impaired to the same extent in wild-type mice that received Il1r1 −/− bone marrow as in Il1r1 −/− mice that received Il1r1 −/− bone marrow (Fig. 2c) . In contrast, CD8 + T cell responses in the Il1r1 −/− mice that received wild-type bone marrow were similar to those of the wild-type control mice that received wild-type bone marrow, in terms of both the number of virus-specific CD8 + T cells ( Fig. 2b) and IFN-γ secretion ( Fig. 2c) , which indicated that IL-1 responsiveness in the radioresistant cells was not required for CD8 + T cell priming. Furthermore, wild-type mice that received Il1r1 −/− bone marrow had a higher viral titer in the BAL fluid at 9 d after infection than that wildtype control mice that received wild-type bone marrow, but Il1r1 −/− mice that received wild-type bone marrow did not (Fig. 2d) . These data indicated that IL-1R signaling in the hematopoietic compartment was required for the optimal generation of virus-specific CD8 + T cells, but IL-1R signaling in the radioresistant compartment was not.
Il1r1

IL-1R signaling in CD8 + T cells is not required for their activation
We next examined the requirement for IL-1R signaling in CD8 + T cells to support their development and population expansion during infection with IAV. To measure epitope-specific CD8 + T cell responses after infection, we used a recombinant IAV strain A/PR8 that expresses the epitope of amino acids 33-41 of lymphocytic choriomeningitis virus glycoprotein (GP(33-41); IAV strain A/PR8-GP33), as well as CD8 + T cells from P14 mice, which transgenically express a T cell antigen receptor that recognizes the GP(33-41) epitope 23 . We obtained IL-1R-deficient antigen-specific CD8 + T cells from the progeny of crosses of P14 mice with Il1r1 −/− mice. We transferred equal numbers of allelically marked wild-type (Thy-1. Fig. 2a ) that we then infected intranasally with IAV strain A/PR8-GP33. We found that at 10 d after infection, wild-type and Il1r1 −/− P14 CD8 + T cells from the lungs produced similar amounts of IFN-γ after restimulation with LCMV GP(33-41) ( Supplementary Fig. 2b ).
In addition, similar numbers of wild-type and Il1r1 −/− P14 CD8 + T cells were present in the lungs, mLNs and spleen of the infected hosts ( Supplementary Fig. 2b ,c). These data indicated that the development of an epitope-specific cytotoxic T lymphocyte response after infection with IAV occurred independently of IL-1R expressed by CD8 + T cells and indicated the involvement of a hematopoietic non-CD8 + T cell population in the IL-1R-dependent priming of cytotoxic T lymphocytes.
Impaired CD8 + T cell priming by Il1r1 −/− DCs We next investigated the importance of IL-1 in supporting the ability of DCs to prime CD8 + T cells after infection with IAV. The priming and population expansion of IAV-specific CD8 + T cells depend on the migration of tissue DCs from the lungs to the draining mLNs mediated by the chemokine receptor CCR7 and also depend on antigen presentation via peptide-MHC class I on DCs [24] [25] [26] . To maximize the antigen load, we challenged wild-type and Il1r1 −/− mice with a high dose (1,000 PFU) of IAV strain A/PR8-GP33. Then, 3 d after infecting the mice, we isolated CD11c + DCs from the mLNs and used those cells to stimulate naive P14 CD8 + T cells ex vivo. DCs isolated from the mLNs of infected Il1r1 −/− mice had less ability to stimulate naive P14 CD8 + T cells to secrete IFN-γ than did DCs isolated from their wild-type counterparts (Fig. 3a) . This was not due to a general defect in antigen presentation by the Il1r1 −/− DCs, because DCs isolated from infected wild-type or Il1r1 −/− mice were able to activate naive P14 CD8 + T cells when exogenous GP(33-41) peptide was added to the culture (Fig. 3b) . These results indicated that in the absence of IL-1R, fewer antigen-presenting DCs were present in the draining lymph nodes to activate naive CD8 + T cell after infection with IAV.
IL-1R controls CCR7 expression and migration of lung DCs
Next we investigated whether IL-1R signaling is critical for the homeostasis of pulmonary DCs. We found that lung CD11c + MHC class II-positive Il1r1 −/− DCs had a less mature phenotype at steady state than that of their wild-type counterparts, with lower surface expression of the costimulatory molecule CD86 and CCR7 (Supplementary Fig. 3a) . Although the total number of DCs in the lungs and mLNs of wild-type and Il1r1 −/− mice remained similar, we observed fewer CD103 + CD11b lo DCs, but not fewer CD11b hi CD103 − DCs, in the lungs and mLNs of Il1r1 −/− mice than in that of wild-type mice at steady state (Supplementary Fig. 3b ). These data indicated that signaling via IL-1R was particularly important in maintaining the number of CD103 + DCs in the respiratory tract.
During infection with IAV, trafficking of respiratory-tract DCs to the draining mLNs, a process that is essential for the generation of T cell immunity, occurs in a CCR7-dependent manner 24 . CD103 + CD11b lo DCs that originate in the lungs are critical in presenting IAV antigens to naive CD8 + T cells in the mLNs, with the peak of this process occurring 48-72 h after infection 26, 27 . In addition, CD11b hi CD103 − DCs are continuously recruited to the mLNs (with peak migration on day 5 after infection) and cross-present to CD8 + T cells in a CD70-dependent manner after infection with IAV 28 . Because IL-1R-deficient mice had lower expression of CCR7 and CD86 at steady state and had fewer antigen-presenting DCs in the mLNs after infection with IAV, we investigated the importance of IL-1R in the migration and activation of respiratory DCs after infection with IAV. CD103 + CD11b lo DCs in Il1r1 −/− lungs did not upregulate CCR7 expression at 18 h after infection with IAV strain A/PR8 (Fig. 4a) , which led to a Fig. 4 ). These data suggested that antigen-bearing CD103 + CD11b lo DCs in Il1r1 −/− mice were less capable of migrating to the draining mLNs than were their wild-type counterparts during the first few days of infection. CD11b hi CD103 − DCs had similar induction of CCR7 expression in wild-type and Il1r1 −/− mice at 18 h after infection. However, these cells do not reach the mLNs in substantial numbers until later time points 28 .
At 3-5 d after infection, the lungs of IAV-infected wild-type and Il1r1 −/− mice were dominated by the inflammatory monocytederived CD11b hi CD103 − DC population 29 , with minimal presence of CD103 + CD11b lo DCs, consistent with published reports 28 ( Fig. 4a and Supplementary Fig. 4a) . However, the newly recruited DCs in the lung of Il1r1 −/− mice were less viable ( Supplementary  Fig. 3c ) and had much lower surface expression of CCR7 and CD86 (Supplementary Fig. 3a ) than did their wild-type counterparts at 3 d after infection. Thus, these data indicated that IL-1R signaling was needed to promote survival of lung DCs after infection, upregulate the expression of CD86 on DCs and induce the expression of CCR7 on lung-resident CD103 + CD11b lo DCs, but not on CD11b hi CD103 − DCs, and on the recruited monocyte-derived CD11b hi CD103 − DCs after infection with IAV.
To directly determine the importance of IL-1R in the migration of lung DCs to the mLNs, we inoculated mice intranasally with fluorescent latex beads together with live IAV strain A/PR8. We used beads mixed with lipopolysaccharide (LPS) as a positive control 30 . We detected a lower frequency of latex bead-bearing lung DCs in the draining mLNs of IAV-infected Il1r1 −/− mice than in their wild-type counterparts (Fig. 4b) . That lower frequency was not due to impaired uptake of latex beads, as the intrinsic ability of Il1r1 −/− bone marrow DCs to take up fluorescent latex beads in vitro was similar to that of wild-type bone marrow DCs (Supplementary Fig. 3d) , and the frequency of DCs and alveolar macrophages bearing latex beads in the BAL remained similar in wild-type and Il1r1 −/− mice after intranasal administration of beads (Supplementary Fig. 3e ). Of note, Il1r1 −/− mice also had a lower frequency of migratory DCs that reached the mLNs after injection of beads mixed with LPS (a TLR4 ligand) or beads mixed with the synthetic RNA duplex poly(I:C) (a TLR3 and Mda5 ligand), but not after injection of beads mixed with the dinucleotide CpG (a TLR9 ligand; Fig. 4b and Supplementary Fig. 5a ). This indicated that the importance of IL-1R in DC migration extended to other stimuli, including the activation of TLR3 and the cytosolic receptor Mda5 (poly(I:C)) and TLR4 (LPS), but not to the activation of TLR9 (CpG). To determine whether the requirement for IL-1R in the priming of CD8 + T cells was restricted to infection with IAV, we infected wild-type and Il1r1 −/− mice intranasally with thymidine kinase-negative herpes simplex virus type 2 (HSV-2). DCs isolated from the mLNs of HSV-2-infected Il1r1 −/− mice were less able to induce the secretion of IFN-γ from naive gBT-I CD8 + T cells (which have transgenic expression of a T cell antigen receptor specific for the immunodominant HSV glycoprotein B peptide of amino acids 498-505) than were their infected wild-type counterparts (Supplementary Fig. 5b ). These data demonstrated that IL-1R promoted the migration of respiratory DCs and the activation of antigenspecific T cells beyond infection with IAV.
We next sought to determine whether IL-1β was sufficient to promote the migration of DCs from the lungs to the mLNs. Intranasal administration of recombinant mouse IL-1β induced substantial surface expression of CD86 and CCR7 and mobilized MHC class IIhigh CD11c + migratory lung DCs 28 to the mLNs of wild-type mice but not those of Il1r1 −/− mice (Fig. 4c) . In addition, intranasal injection of recombinant IL-1α was sufficient to upregulate surface expression of CD86 and CCR7 on migratory CD103 + CD11b lo DCs in the lungs and mLNs (Supplementary Fig. 6b ). Unlike CD11b hi lung DCs, the migratory CD103 + CD11b lo DCs were particularly responsive to activation induced by either IL-1β or IL-1α (Supplementary Fig. 6 ). Collectively, these results indicated that 
IL-1R-adaptor MyD88 signaling in DCs drives their migration
Next we investigated whether signaling via IL-1R and the adaptor MyD88 in DCs was sufficient to drive their activation and migration to the mLNs during infection with IAV. We used the progeny of transgenic mice that express MyD88 under the control of the Cd11c promoter crossed with Myd88 −/− mice 31 . In these mice, MyD88 is expressed only in CD11c + DCs and some macrophages (including CD11c + alveolar macrophages) but not in B cells or T cells (C. Pasare, personal communications). DCs in these mice migrated as efficiently from the lungs to the draining mLNs as did those in wild-type mice and had expression of CCR7 similar to that of wild-type lung DCs, despite having slightly lower expression of CD86 at 2.5 d after infection ( Fig. 5a and Supplementary Fig. 5d ). Furthermore, unlike MyD88 −/− mice, these transgenic mice generated an effective virusspecific CD8 + T cell response in the lung 7 d after sublethal infection with IAV strain A/PR8 (Fig. 5b,c) . These results indicated that MyD88-dependent signaling in DCs alone was sufficient to induce the migration of DCs from the lungs to the lymph nodes to promote CD8 + T cell responses after infection with IAV. Next we determined whether intranasal delivery of wild-type DCs could restore the defective CD8 + T cell response in IL-1R-deficient mice after infection with IAV. We injected wild-type or IL-1R-deficient bone marrow DCs intranasally together with live recombinant IAV strain A/PR8-GP33 into wild-type or Il1r1 −/− mice previously given adoptive transfer of naive P14 CD8 + T cells. By day 7 after infection, P14 CD8 + T cells were readily detectable in the draining mLNs of wild-type mice but not in those of Il1r1 −/− mice. Notably, intranasal injection of wild-type bone marrow DCs fully restored the population expansion of P14 CD8 + T cells in Il1r1 −/− mice, but intranasal injection of Il1r1 −/− bone marrow DCs did not (Fig. 6) . These data showed that wild-type DCs were able to restore the priming of CD8 + T cells in the mLNs of Il1r1 −/− hosts, which suggested that the responsiveness of the migrant DCs to IL-1 was sufficient for the priming of CD8 + T cells after infection with IAV.
Indirectly activated DCs drive the CD8 + T cell response Studies using protein plus adjuvant have shown that bystander DCs activated by inflammatory signals cannot substitute for PAMPexposed DCs directly activated by PRR signaling in the successful priming of CD4 + T cells 19 and CD8 + T cells 20 . Thus far, our data indicated that priming of CD8 + T cells after infection with live IAV did not depend on PRR signaling but relied on the inflammasome-IL-1R axis. We next determined whether direct activation of DCs by NLR inflammasomes was needed to couple damage recognition to the activation of adaptive CD8 + T cell responses. For this, we generated a mixed-bone marrow chimera model based on a published, established strategy 20 in which half the APCs cannot directly activate caspase-1 but can present to CD8 + T cells, whereas the other half can activate caspase-1 for the processing and secretion of inflammasome-dependent cytokines but cannot present to CD8 + T cells after infection with IAV (Supplementary Fig. 7a ). In these chimeric mice (lethally irradiated wild-type C57BL/6 host mice given Casp1 (Fig. 7) . These data indicated that direct recognition of IAV by DCs via NLR inflammasomes was not required for the processing of viral antigens and their presentation on MHC class I.
To assess the possibility that IL-1 responsiveness in the antigenpresenting DCs was required for the priming of H-2D b -restricted virus-specific CD8 + T cells, we generated chimeras in which half the APCs were able to signal through IL-1R but were not able to present to H-2D b -restricted CD8 + T cells, whereas the other half lacked IL-1R but were able to present to CD8 + T cells (lethally irradiated wildtype C57BL/6 host mice given Fig. 7b) , which indicated that an antiviral mechanism not dependent on CD8 + T cells compensated for the impaired CD8 + T cell responses in these mice. Together these data demonstrated that cell-intrinsic IL-1 responsiveness of DCs, but not innate recognition of IAV via NLR inflammasomes, was required for the activation of virus-specific CD8 + T cell responses after infection with IAV.
DISCUSSION
IAV is recognized by two classes of innate recognition receptors: those that rely on detection of viral PAMPs (TLR7, TLR8 and RIG-I), and those that monitor virus-inflicted damage (NLRPs). In this study we examined the relative contributions of these classes of innate viral 
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A r t i c l e s sensors in the development of an adaptive CD8 + T cell response after infection with IAV. After infection with a physiological dose of IAV in vivo, mice that lacked both TLR7 and MAVS were able to mount a robust virus-specific CD8 + T cell response to IAV. In contrast, ASCdependent inflammasomes 16 and IL-1R were required for the optimum virus-specific CD8 + T cell response to IAV. Expression of IL-1R in hematopoietic cells was essential for the activation of cytotoxic T lymphocytes, but expression of IL-1R in CD8 + T cells themselves was not. IL-1R signaling was critical in regulating both constitutive and infection-induced activation of lung-resident DCs. Furthermore, MyD88 signaling in DCs alone was sufficient for the migration of DCs from the lungs to the mLNs and for the priming of CD8 + T cells after infection with IAV. Likewise, intranasal administration of wildtype DCs was sufficient to restore the priming of CD8 + T cells in IL-1R-deficient mice after infection with IAV. Moreover, our data indicated that direct stimulation of APCs through IL-1R was required for antigen presentation to CD8 + T cells after infection with IAV, but activation of caspase-1 was not. These data indicated that an inflammatory cytokine, but not recognition of PAMPs, was both required and sufficient for conveying the signals necessary for the generation of virus-specific CD8 + T cells after infection with IAV. Our findings have shown that after infection with a live virus, the rules that govern DC activation for CD8 + T cell priming differ considerably from those that apply after immunization with a non-live vaccine. Published work has demonstrated that direct recognition of PAMPs by antigen-presenting DCs is required for productive activation of CD4 + T cells 19 and CD8 + T cells 20 after vaccination with protein antigen plus adjuvant. The requirement for direct PAMP recognition extends even to the phagosome in which the microbial antigens are processed for MHC class II presentation 32 . In contrast, our data indicated that after infection with IAV, activation of DCs in trans through IL-1R was both required and sufficient to promote the population expansion of virus-specific CD8 + T cells. These seemingly conflicting results raise several questions. First, why is PAMP recognition not sufficient to induce DC activation and priming of CD8 + T cells after infection with IAV? One possible explanation is that DCs that recognize IAV through cytosolic sensors are necessarily infected by the virus, which renders them unable to serve their antigen-presenting functions in the mLNs 33, 34 . This may also be the case for infection with HSV-2, as we noted fewer antigen-presenting DCs in the lymph nodes of IL-1R-deficient mice. The other possibility is that the DC subset responsible for priming CD8 + T cell responses does not have the appropriate PRRs. In this context, the CD103 + tissue-resident DCs in the lung do not express TLR7 (ref. 35 ), a key PRR associated with recognition of IAV. Second, why are other inflammatory cytokines unable to serve the function of IL-1 in its absence? It is possible that as IL-1R, like TLRs, contains a Toll-IL-1R domain and signals through MyD88, it induces sets of gene expression that overlap with those induced by TLR signaling. Third, why is IL-1R signaling insufficient to activate DCs after immunization with protein plus adjuvant? This may relate to the extent of IL-1 secretion induced by a typical immunization relative to that induced by live viruses 10 . Whether the NLR inflammasomes and the cytokines secreted through this pathway represent a common strategy used by the host to stimulate adaptive immune responses to pathogens that evade innate sensors remains to be determined.
Pulmonary DCs are critical for the priming of naive CD8 + T cells in the lungs and for efficient viral clearance after respiratory infection with IAV 26 . In our study here, we found that IL-1R was important in maintaining the homeostasis and maturation of pulmonary DCs in the lungs at steady state and in activating and mobilizing the migration of tissue DCs in the respiratory tract after infection with IAV. In addition, DCs in IL-1R-deficient mice had an impaired ability to survive in the lungs after infection with IAV. The overall diminished priming of CD8 + T cells in IL-1R-deficient mice was probably due to a combined effect of a lower frequency and number of CD103 + DCs at steady state and impaired CCR7 expression after infection with IAV, which resulted in fewer antigen-presenting DCs in the lymph node. The importance of IL-1R signaling in promoting the migration and activation of respiratory DCs was not restricted to infection with IAV and extended to other stimuli, including activation of TLRs and infection with HSV-2. Moreover, in other experimental systems, IL-1R signaling activates DCs for the induction of CD4 + T cell-mediated autoimmune heart disease 36 . In the skin, IL-1β is essential for the activation and migration of Langerhans cells to the lymph nodes during contact-hypersensitivity responses 37 . Thus, in addition to PAMPs, IL-1R can (in certain situations) trigger the migration of DCs by upregulating CCR7 expression and can promote the maturation and survival of DCs that leads to optimal priming of CD8 + T cells.
Our study has identified a molecular signature of innate signals critical for the development of robust antiviral CD8 + T cell immunity after infection with a live virus. Our findings highlight a contingency system for priming CD8 + T cell responses when a viral infection renders the host cells, particularly DCs, unable to serve their antigenpresenting functions. Our results suggest a potential use of IL-1 as an adjuvant in vaccine settings. Conversely, IL-1 may serve a detrimental role by priming autoreactive T cells against self antigens, even in the absence of PAMPs. The development of new approaches for using the immunogenicity of IL-1 signaling in DCs directed at desired antigens may make this cytokine an ideal adjuvant in the future.
METHODS
Methods and any associated references are available in the online version of the paper.
